16 June 2022: Clinical Research
Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era
Mevlut Tamer Dincer 1ABCDEF , Zeynep Toker Dincer 2BCE* , Oguz Kagan Bakkaloglu 3CEF , Serkan Feyyaz Yalin 4BE , Sinan Trabulus 1ADE , Aykut Ferhat Celik 3AE , Nurhan Seyahi 1CDE , Mehmet Riza Altiparmak 1ACDEDOI: 10.12659/MSM.936497
Med Sci Monit 2022; 28:e936497
Table 3 Renal manifestations in patients with Crohn disease and ulcerative colitis.
| Crohn’s disease (n=55) | Ulcerative colitis (n=50) | p | |
|---|---|---|---|
| Microscopic hematuria | 38 (69.1) | 37 (74.0) | 0.667 |
| Macroscopic hematuria | 10 (18.2) | 10 (20.0) | 0.812 |
| Proteinuria | 11 (20.0) | 4 (8.0) | 0.098 |
| Renal calculi | 45 (81.8) | 45 (90.0) | 0.273 |
| Secondary (AA) amyloidosis | 6 (10.9) | 0 (0.0) | |
| Glomerulonephritis | 0 (0.0) | 3 (6.0) | 0.100 |
| Acute interstitial nephritis | 0 (0.0) | 1 (2.0) | 0.470 |
| Acute kidney injury | 4 (7.3) | 3 (6.0) | 0.794 |
| Chronic kidney disease | 4 (7.3) | 1 (2.0) | 0.365 |
| Significant p values are written in bold. | |||